Market revenue in 2021 | USD 16.6 million |
Market revenue in 2030 | USD 32.2 million |
Growth rate | 7.6% (CAGR from 2021 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Clinical |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preclinical, Clinical |
Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 67.47% in 2021. Horizon Databook has segmented the Mexico large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The large molecule bioanalytical testing market of Mexico is driven by growing number of clinical trials in the country. For instance, Mexico conducted 6,446 clinical trials between 1999 and 2019, according to WHO’s ICTRP.
This contributes to around 1.23% of the total clinical trials conducted globally in the same period. Furthermore, according to the World Bank, the healthcare expenditure of Mexico was 5.4% of its GDP in 2018. This expenditure offers a decent environment for growth of large molecule bioanalytical testing market.
Furthermore, high geriatric population will augment the need for advanced health care, boosting the market. For instance, according to OECD, 7.2% of the Mexican population was aged 65 or above in 2018.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico large molecule bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Mexico large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account